Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Eli Lilly and Company (LLY)

116.79   -0.02 (-0.02%) 05-24 16:04
Open: 117.53 Pre. Close: 116.81
High: 117.55 Low: 116.45
Volume: 2,086,492 Market Cap: 107544M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 117.671 - 118.313 118.313 - 118.847
Low: 114.863 - 115.679 115.679 - 116.357
Close: 115.564 - 116.806 116.806 - 117.838

Technical analysis

as of: 2019-05-26 10:12:14 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 137.33     One year: 140.17
Support: Support1: 113.65    Support2: 94.56
Resistance: Resistance1: 117.58    Resistance2: 120.01
Pivot: 116.13
Moving Average: MA(5): 116.88     MA(20): 116.61
MA(100): 120.82     MA(250): 109.88
MACD: MACD(12,26): -1.08     Signal(9): -1.52
Stochastic oscillator: %K(14,3): 72.13     %D(3): 65.90
RSI: RSI(14): 45.67
52-week: High: 132.13  Low: 81.65  Change(%): 41.1
Average Vol(K): 3-Month: 1416525  10-Days: 340294

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
LLY has closed below upper band by 31.1%. Bollinger Bands are 60.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to LLY's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 25 May 2019 16:08:00 Z
What Is Nektar Therapeutics' New Game Plan?

Fri, 24 May 2019 16:14:08 Z
Nektar (NKTR) Announces Formation of CNS-Focused Subsidiary

Fri, 24 May 2019 15:21:40 Z
Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates

Thu, 23 May 2019 17:12:48 Z
Amgen (AMGN) Offers to Acquire Drug Discovery Platform

Thu, 23 May 2019 15:21:20 Z
Lilly (LLY) Launches Half-Priced Version of Humalog Insulin

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 970.83
Shares Float (M) 966.67
% Held by Insiders
% Held by Institutions
Shares Short (K) 26967
Shares Short P. Month (K)

Stock Financials

EPS 5.560
EPS Est. Current Year 4.200
EPS Est. Next Year 4.630
EPS Est. Next Quarter 1.090
Forward EPS 5.319
Book Value (p.s.) 45.720
PEG Ratio 1.89
Profit Margin 26.22
Operating Margin 25.45
Return on Assets (ttm) 15.5
Return on Equity (ttm) 76.2
Qtrly Rev. Growth 2.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 248.40
Operating Cash Flow (M) 5400.00
Levered Free Cash Flow (M) 3020.00

Stock Valuations

P/E 21.01
P/E Growth Ratio
P/BV 2.55
P/S 4403920384.00
P/CF 21.00

Dividends & Splits

Dividend 2.209
Dividend Yield 0.02
Dividend Pay Date 2019-06-10
Ex-Dividend Date 2019-05-16
Forward Dividend 2.580
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.